Is Somatostatin Receptor and Dopamine Receptor profiling useful in the management of silent somatotroph tumors?
J Endocrinol Invest
; 43(6): 859-863, 2020 Jun.
Article
in En
| MEDLINE
| ID: mdl-31898311
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pituitary Neoplasms
/
Adenoma
/
Receptors, Somatostatin
/
Receptors, Dopamine D2
/
Neuroendocrine Tumors
/
Somatotrophs
Type of study:
Diagnostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Endocrinol Invest
Year:
2020
Type:
Article
Affiliation country:
Spain